Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Repurposing epigenetic inhibitors to target the Clostridioides difficile-specific DNA adenine methyl

Journal Article · · Epigenetics

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; National Institutes of Health (NIH); OTHER
OSTI ID:
1900910
Journal Information:
Epigenetics, Vol. 17, Issue (9)
Country of Publication:
United States
Language:
ENGLISH

References (69)

Epigenetics and meditation August 2019
Advances in epigenetics link genetics to the environment and disease July 2019
Diet, Nutrition, and Cancer Epigenetics July 2016
Epigenetics and Bacterial Infections December 2012
Targeting host epigenetic machinery: TheListeriaparadigm April 2020
Epigenetic therapy of cancer: past, present and future January 2006
PRMTs and Arginine Methylation: Cancer’s Best-Kept Secret? November 2019
T herapeutic targeting of chromatin: status and opportunities June 2021
Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia April 2021
The antibiotic paradox: why companies can’t afford to create life-saving drugs August 2020
Why big pharma has abandoned antibiotics October 2020
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance March 2017
Possible drugs for the treatment of bacterial infections in the future: anti-virulence drugs July 2020
Conserved DNA Methyltransferases: A Window into Fundamental Mechanisms of Epigenetic Regulation in Bacteria January 2021
Beyond Restriction Modification: Epigenomic Roles of DNA Methylation in Prokaryotes October 2021
Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes April 2020
Pseudomembranous colitis May 2015
Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection March 2020
Activity of Hospital Disinfectants against Vegetative Cells and Spores of Clostridioides difficile Embedded in Biofilms December 2019
Receipt of Antibiotics in Hospitalized Patients and Risk for Clostridium difficile Infection in Subsequent Patients Who Occupy the Same Bed December 2016
Murine Intrarectal Instillation of Purified Recombinant Clostridioides difficile Toxins Enables Mechanistic Studies of Pathogenesis March 2021
The Relative Role of Toxins A and B in the Virulence of Clotridioides difficile December 2020
Anti-virulence strategies for Clostridioides difficile infection: advances and roadblocks October 2020
Insights into the Role of Human Gut Microbiota in Clostridioides difficile Infection January 2020
Clostridioides (Clostridium) difficile infection: current and alternative therapeutic strategies March 2018
Therapies to modulate gut microbiota: Past, present and future February 2020
Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection September 2020
Increasing antibiotic resistance in Clostridioides difficile: A systematic review and meta-analysis August 2019
Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile April 2021
The Integrity of Heme Is Essential for Reproducible Detection of Metronidazole-Resistant Clostridioides difficile by Agar Dilution Susceptibility Tests August 2021
Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes June 2021
Epigenomic characterization of Clostridioides difficile finds a conserved DNA methyltransferase that mediates sporulation and pathogenesis November 2019
Cephamycins inhibit pathogen sporulation and effectively treat recurrent Clostridioides difficile infection August 2019
The early stage peptidoglycan biosynthesis Mur enzymes are antibacterial and antisporulation drug targets for recurrent Clostridioides difficile infection February 2020
Clostridioides difficile specific DNA adenine methyltransferase CamA squeezes and flips adenine out of DNA helix June 2021
Many paths to methyltransfer: a chronicle of convergence June 2003
Crystal structure of the conserved core of protein arginine methyltransferase PRMT3 July 2000
Insights into histone code syntax from structural and biochemical studies of CARM1 methyltransferase September 2007
Structural insights into protein arginine symmetric dimethylation by PRMT5 December 2011
Structure and Substrate Recognition of the Escherichia coli DNA Adenine Methyltransferase April 2006
Transition from Nonspecific to Specific DNA Interactions along the Substrate-Recognition Pathway of Dam Methyltransferase May 2005
The cell cycle-regulated DNA adenine methyltransferase CcrM opens a bubble at its DNA recognition site October 2019
Human MettL3–MettL14 complex is a sequence-specific DNA adenine methyltransferase active on single-strand and unpaired DNA in vitro December 2019
Human MettL3-MettL14 RNA adenine methyltransferase complex is active on double-stranded DNA containing lesions June 2021
Enzymatic characterization of three human RNA adenosine methyltransferases reveals diverse substrate affinities and reaction optima January 2021
The inactive Dnmt3b3 isoform preferentially enhances Dnmt3b-mediated DNA methylation October 2020
Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation February 2012
Methyltransferase-Glo: a universal, bioluminescent and homogenous assay for monitoring all classes of methyltransferases March 2016
Towards automated crystallographic structure refinement with phenix.refine March 2012
Features and development of Coot March 2010
A New Generation of Crystallographic Validation Tools for the Protein Data Bank October 2011
The Escherichia coli Dam DNA Methyltransferase Modifies DNA in a Highly Processive Reaction June 2002
The double role of methyl donor and allosteric effector of S-adenosyl-methionine for Dam methylase of E. coli August 1990
Dam methylase from Escherichia coli : kinetic studies using modified DNA oligomers: hemimethylated substrates January 1995
Phage T4 DNA [N 6 -Adenine] Methyltransferase: Kinetic Studies Using Oligonucleotides Containing Native or Modified Recognition Sites January 1998
Differential binding of S -adenosylmethionine S -adenosylhomocysteine and Sinefungin to the adenine-specific DNA methyltransferase M. Taq I 1 1Edited by T. Richmond January 1997
Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors January 2012
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor July 2011
537MO First-in-human study of JNJ-64619178, a protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced cancers September 2020
Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response May 2020
Potent inhibition of DOT1L as treatment of MLL-fusion leukemia August 2013
Inhibition of Methyltransferase DOT1L Sensitizes to Sorafenib Treatment AML Cells Irrespective of MLL-Rearrangements: A Novel Therapeutic Strategy for Pediatric AML July 2020
Substituted purine and 7-deazapurine compounds as modulators of epigenetic enzymes: a patent evaluation (WO2012075381) March 2013
Cancer synthetic vulnerabilities to protein arginine methyltransferase inhibitors August 2021
Chemical probes for protein arginine methyltransferases March 2020
The architecture of the Gram-positive bacterial cell wall April 2020
The CWB2 Cell Wall-Anchoring Module Is Revealed by the Crystal Structures of the Clostridium difficile Cell Wall Proteins Cwp8 and Cwp6 March 2017
New class of precision antimicrobials redefines role of Clostridium difficile S-layer in virulence and viability September 2017
Phospholipid profiles of Clostridium difficile October 1996